Article

Exploring the transcriptomic landscape of BLCA: SHTN1 as a key player in photodynamic therapy response

2024-03-29

Abstract excerpt

<title>Abstract</title> <p>Background A high recurrence rate and a tendency to progress to more advanced, invasive stages characterize bladder urothelial carcinoma (BLCA), the ninth most common malignant tumor worldwide. Despite its potential, photodynamic therapy (PDT), a minimally invasive treatment, remains underutilized in BLCA management. This study focuses on identifying key genes that influence BLCA progr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5a2cb524-432e-5e0a-818f-70166e450b3b
DOI: 10.21203/rs.3.rs-4021160/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring the transcriptomic landscape of BLCA: SHTN1 as a key player in photodynamic therapy responseDOI 10.21203/rs.3.rs-4021160/v1Read

Data-mining-based biomarker evaluation and experimental validation of SHTN1 for bladder cancerSemantic proximity Read

Construction of a new prognosis prediction model and immune infiltration analysis of bladder urothelial cancer based on disulfidptosis-related immune genesSemantic proximity Read

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerSemantic proximity Read

Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity Read

Disulfidptosis related immune genes drive prognostic model development and tumor microenvironment characterization in bladder urothelial carcinomaSemantic proximity Read

Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicineSemantic proximity Read

Integrating Stemness Features and Immune Microenvironment in a Prognostic Model for Bladder Cancer TreatmentSemantic proximity Read

Gene expression and coexpression alterations marking evolution of bladder cancerSemantic proximity Read

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancerSemantic proximity Read

Prognostic feature based on androgen-responsive genes in bladder cancer and screening for potential targeted drugsSemantic proximity Read